Lauren I. Aronson
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Addition of oncolytic virotherapy to clinical isolated limb perfusion for melanoma and sarcoma activates antitumor immunity.
Journal: Journal for immunotherapy of cancer
Published: August 27, 2025
Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma: Results of the Proof-of-Concept iMYC Study.
Journal: Current oncology (Toronto, Ont.)
Published: February 03, 2022
SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance.
Journal: Cancer research
Published: December 21, 2021
The Mutational Concordance of Fixed Formalin Paraffin Embedded and Fresh Frozen Gastro-Oesophageal Tumours Using Whole Exome Sequencing.
Journal: Journal of clinical medicine
Published: December 03, 2020
Clonal diversity of MYC amplification evaluated by fluorescent in situ hybridisation and digital droplet polymerase chain reaction in oesophagogastric cancer: Results from a prospective clinical trial screening programme.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 19, 2019
HSF1 Is Essential for Myeloma Cell Survival and A Promising Therapeutic Target.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 20, 2017
Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer.
Journal: Gut
Published: April 27, 2017
Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 19, 2015
A novel functional role for MMSET in RNA processing based on the link between the REIIBP isoform and its interaction with the SMN complex.
Journal: PloS one
Published: January 20, 2014
The combination of HDAC and aminopeptidase inhibitors is highly synergistic in myeloma and leads to disruption of the NFκB signalling pathway.
Journal: Oncotarget
Published: July 10, 2013
Hsp70 inhibition induces myeloma cell death via the intracellular accumulation of immunoglobulin and the generation of proteotoxic stress.
Journal: Cancer letters
Published: May 24, 2013
Last Updated: 09/26/2026